FLCCC Alliance calls on national health authorities to immediately review medical evidence showing the efficacy of ivermectin for the prevention of COVID-19 and as an early outpatient treatment.

Authors: Kalfas S, Visvanathan K, Chan K, Drago J doi: https://doi.org/10.1101/2020.11.30.20236570 Abstract Introduction Ivermectin is a commonly used antihelminthic agent with over 35 years of established safety data in humans. Recent data demonstrates antiviral activity in vitro against SARS-CoV-2, in addition to a range of viruses. In vitro and animal models also provide evidence of [...]

FLCCC Alliance News Conference: Medical Evidence of Ivermectin— Effectively Prevent & Treat COVID-19 - Dr Pierre Kory gave a webinar hosted by YPO Gold’s Southern California Chapter for hundreds of CEOs within the network internationally.

The Latest Results of Ivermectin’s Success in Treating Outbreaks of COVID-19 including charts and data by Juan Chamie.

Authors: Kalfas S, Visvanathan K, Chan K, Drago J. doi: https://doi.org/10.1101/2020.11.30.20236570 Abstract Introduction Ivermectin is a commonly used antihelminthic agent with over 35 years of established safety data in humans. Recent data demonstrates antiviral activity in vitro against SARS-CoV-2, in addition to a range of viruses. In vitro and animal models also provide evidence of [...]

Authors: Peralta EG, Fimia-Duarte R, Cardenas JW, Dominguez DV, Segura RB Abstract Covid-19 is one of the viral infections that have always accompanied us. In some years harmless, but from time to time with a higher risk potential. What is particularly unsettling for us is that transmission often occurs from a [...]

Authors:Hellwig MD, Maia A. PMID: PMC7698683 DOI: 10.1016/j.ijantimicag.2020.106248 Abstract As COVID-19 (coronavirus disease 2019) continues to rapidly spread throughout the world, the incidence varies greatly among different countries. These differences raise the question whether nations with a lower incidence share any medical commonalities that could be used not only to explain that lower incidence [...]

The severe acute respiratory syndrome-coronavirus-2 pandemic has had devastating health and socio-economic implications worldwide. Data indicate that SARS-CoV2 is spread by respiratory droplets and contact.

Ivermectin in the prophylaxis and treatment of COVID-19 - Dr. Kory reviews the evidence in support of ivermectin as a COVID-19 treatment.

Background Ivermectin is one among several potential drugs explored for its therapeutic and preventive role in COVID-19 infection. The study was aimed to explore the association between ivermectin prophylaxis and development of COVID-19 infection among healthcare workers.